INO financials

Inovio Pharmaceuticals (INO) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.

INO income statement, yearly

YearRevenueGross profitOperating incomeNet incomeEPS
2025$65.34K–-$86.82M-$84.95M-1.81
2024$217.76K–-$112.40M-$107.25M-3.95
2023$832.01K–-$143.94M-$135.12M-6.09
2022$10.26M–-$267.57M-$279.82M-14.07
2021$1.77M–-$301.22M-$303.66M-17.45
2020$7.41M–-$124.08M-$166.41M-12.84